Results 21 to 30 of about 4,927,702 (244)

Effect of recurrent invasive pneumococcal disease on serum anti-pneumolysin IgG titres in HIV infected adults. [PDF]

, 2009
We measured serum anti-pneumolysin IgG concentrations in a prospective cohort of 34 HIV infected adults who developed recurrent pneumococcal bacteraemia, and compared baseline levels with HIV positive and HIV negative control subjects that remained free ...
Gordon, Stephen B, Zijlstra, Ed E., Etuwewe, Onajite M., Etuwewe, Onajite M, Zijlstra, Ed E, Gordon, Stephen, Hollingshead, Susan, Tolmie, Helen, French, Neil, Gordon, Stephen B., Swann, Natalie, Faragher, Brian   +11 more
core   +1 more source

Epidemiology, vaccine effectiveness, and risk factors for mortality for pneumococcal disease among hospitalised adults in Singapore: a case-control study

BMC Infectious Diseases, 2020
Background Streptococcus pneumoniae infections can lead to severe morbidity and mortality, especially in patients with invasive pneumococcal disease (IPD).
Tyson Chan, Min Zhi Tay, Win Mar Kyaw, Angela Chow, Hanley J. Ho   +4 more
doaj   +1 more source

A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults. [PDF]

, 2010
BACKGROUND: Streptococcus pneumoniae is a leading and serious coinfection in adults with human immunodeficiency virus (HIV) infection, particularly in Africa.
Zijlstra, EE, Molyneux, Malcolm E, White, Sarah A., Mwaiponya, Martin, Mwalukomo, Thandie, Gordon, Stephen, Zijlstra, Eduard E, Longwe, Herbert, French, N, Mwalukomo, T, White, SA, French, Neil, Gordon, SB, Mwaiponya, M, Gilks, CF, Gilks, Charles F, Mwafulirwa, Gershom, Molyneux, Malcolm E., Mwafulirwa, G, Molyneux, ME, Gordon, Stephen B., Gordon, Stephen B, White, Sarah; id_orcid, Longwe, H, Gilks, Charles F., White, Sarah A, Zijlstra, Eduard E.   +26 more
core   +1 more source

INVASIVE PNEUMOCOCCAL DISEASES IN CHILDREN AGED 1-59 MONTHS IN SICILY, ITALY: IMPORTANCE OF ACTIVE FAMILY PAEDIATRICIAN SURVEILLANCE AND VACCINATION COVERAGE. [PDF]

Euromediterranean Biomedical Journal, 2014
Purpose: Aim of this study was to analyze pediatric invasive pneumococcal disease rates several years after the implementation of infant pneumococcal vaccination. Methods: The study was carried out in Sicily and involved about 30,000 children, aged 1-
Emanuele Amodio
doaj   +1 more source

Risk factors for pneumococcal disease in persons with chronic medical conditions: Results from the LIFE Study

International Journal of Infectious Diseases, 2022
Objectives: This study aimed to identify the risk factors for pneumococcal disease. Methods: The study was performed using insurance claims data from the residents of 12 Japanese municipalities.
Haruhisa Fukuda, Hiroaki Onizuka, Naoaki Nishimura, Kosuke Kiyohara   +3 more
doaj   +1 more source

Pneumococcal carriage in sub-Saharan Africa--a systematic review. [PDF]

, 2014
BACKGROUND: Pneumococcal epidemiology varies geographically and few data are available from the African continent. We assess pneumococcal carriage from studies conducted in sub-Saharan Africa (sSA) before and after the pneumococcal conjugate vaccine (PCV)
Bottomley, Christian, Andrew Hall, Richard A. Adegbola (20657), Hall, Andrew, Hall Andrew, Effua Usuf (334925), Effua Usuf, Christian Bottomley, Adegbola Richard A., Bottomley Christian, Adegbola, Richard A, Usuf, Effua, Usuf Effua, Andrew Hall (223292), Richard A Adegbola, Christian Bottomley (144483)   +15 more
core   +1 more source

Pneumococcal disease and use of pneumococcal vaccines in Taiwan

Clinical and Experimental Vaccine Research, 2015
The use of pneumococcal vaccine plays an important role for prevention of invasive pneumococcal disease (IPD). However, introducing the pneumococcal vaccine into the national immunization program (NIP) is complex and costly. The strategy of progressively integrating the pneumococcal conjugate vaccine (PCV) into the NIP in Taiwan provides valuable ...
Sung-Hsi Wei, Chuen-Sheue Chiang, Chyi-Liang Chen, Cheng-Hsun Chiu   +3 more
openaire   +2 more sources

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease. [PDF]

, 2010
BACKGROUND: The 7-valent pneumococcal conjugate vaccine has been introduced in national immunisation programmes of most industrialised countries and recently in two African GAVI eligible countries (Rwanda and The Gambia). However the long term effects of
George, Robert, Robert George, Y.H. Choi, Miller, Elizabeth, Edmunds, John W., Elizabeth Miller, Melegaro, Alessia, Yoon Hong Choi, E. Miller, Choi, Yoon Hong, Gay, Nigel J, Edmunds, W John, Nigel J Gay, R. George, W John Edmunds, Alessia Melegaro, N.J. Gay, W.J. Edmunds, Gay, Nigel J., George Robert, Miller Elizabeth, Edmunds W John, Choi Yoon, Gay Nigel J, Melegaro Alessia   +24 more
core   +2 more sources

Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis. [PDF]

, 2012
OBJECTIVE: To estimate the cost effectiveness of vaccinating people with high risk conditions against invasive pneumococcal disease using the 13 valent pneumococcal conjugate vaccine.
Edmunds, W. John, van Hoek, Albert Jan, Trotter, Caroline L, Rozenbaum, Mark H., C. L. Trotter, Miller, Elizabeth, Rozenbaum, Mark H, D. Fleming, Trotter, Caroline L., E. Miller, M. H. Rozenbaum, Edmunds, W John, W. J. Edmunds, Fleming, Douglas, A. J. van Hoek   +14 more
core   +2 more sources

Promising Expectations for Pneumococcal Vaccination during COVID-19

Vaccines, 2021
The emergence of new viral infections has increased over the decades. The novel virus is one such pathogen liable for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, popularly known as coronavirus disease 2019 (COVID-19).
Hyobin Im, Jinhui Ser, Uk Sim, Hoonsung Cho   +3 more
doaj   +1 more source